Comparing balloon types for leg artery treatment
Part of Heart & circulation clinical trials.
This trial tests if using a special 'chocolate' balloon before a drug-coated balloon is better than a standard balloon for opening narrowed or blocked arteries in the leg. It may help people with leg pain or wounds from poor blood flow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a narrowed or blocked artery in your upper leg that has not been treated before.
- Your leg pain or wounds are moderate to severe (Rutherford category 3, 4, or 5).
- The blockage is at least 70% or completely blocked.
- You have at least one open blood vessel below the knee to your foot.
- You are expected to live more than 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a special balloon coated with a drug (paclitaxel) to treat narrowed or blocked arteries in the leg. It aims to see how well this balloon works to keep the artery open.
This trial is testing a special balloon coated with the drug paclitaxel to open up long blockages in the leg artery (femoropopliteal). The goal is to see if it is safe and effective for improving blood flow and symptoms like pain or ulcers.
This trial uses a special balloon (Shockwave IVL) to break up calcium in leg artery blockages, improving blood flow and reducing pain. It's for people with moderate to severe calcium buildup in the femoropopliteal artery.
This trial tests a special balloon called the Chocolate Balloon Catheter to open blocked leg arteries. It may help people with peripheral artery disease avoid more invasive surgery.
This study compares two ways of preparing a blocked leg artery before using a drug-coated balloon to open it. It aims to see if using a special scoring balloon helps the treatment work better.
This trial tests a special balloon coated with a drug (paclitaxel) to open blocked leg arteries, aiming to improve blood flow and reduce symptoms like leg pain when walking. It is for people with moderate to severe leg artery disease who have not had prior stents or bypass in the treated area.
Hear when a new Femoropopliteal Artery Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.